Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Querfeld

Showing results (61-70 of 136) with videos related to

Pageof 14
Sort By:
Journal of the American Academy of Dermatology|January 18, 2011
Disseminated follicular eruption during therapy with the MEK inhibitor AZD6244Christiane Querfeld, Keith Duffy, George Magel, et al.
Dermatology Online Journal|October 6, 2015
Jejunal adenocarcinoma with cutaneous metastasisEsther Chung, Ericka Syklawer, Melissa P Pulitzer, et al.
Pathology|November 14, 2014
Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factorsMelissa Pulitzer, Patricia L Myskowski, Steven M Horwitz, et al.
American Journal of Clinical Dermatology|May 10, 2022
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial DataChristiane Querfeld, Julia J Scarisbrick, Chalid Assaf, et al.
Leukemia & Lymphoma|October 29, 2009
Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer CenterChristiane Querfeld, Neha Mehta, Steven T Rosen, et al.
Dermatology and Therapy|November 27, 2024
Chlormethine Gel for Treatment of Patients with Mycosis Fungoides: Best Practices and Guidance to CliniciansLarisa Geskin, Christiane Querfeld, Emmilia Hodak, et al.
Journal of the American Academy of Dermatology|March 21, 2007
Phase II trial of subcutaneous injections of human recombinant interleukin-2 for the treatment of mycosis fungoides and Sézary syndromeChristiane Querfeld, Steven T Rosen, Joan Guitart, et al.
Frontiers in Medicine|February 2, 2024
Expert opinions and clinical experiences with chlormethine gel as maintenance treatment for patients with mycosis fungoidesLarisa Geskin, Christiane Querfeld, Emmilia Hodak, et al.
Best Practice & Research. Clinical Haematology|October 6, 2019
Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndromeXochiquetzal U Martinez, Cosimo Di Raimondo, Farah R Abdulla, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 6, 2023
Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment ExperiencesLarisa J Geskin, James T Angello, Martine Bagot, et al.
Pageof 14

Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Journal of the American Academy of Dermatology|January 18, 2011
Disseminated follicular eruption during therapy with the MEK inhibitor AZD6244Christiane Querfeld, Keith Duffy, George Magel, et al.
Dermatology Online Journal|October 6, 2015
Jejunal adenocarcinoma with cutaneous metastasisEsther Chung, Ericka Syklawer, Melissa P Pulitzer, et al.
Pathology|November 14, 2014
Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factorsMelissa Pulitzer, Patricia L Myskowski, Steven M Horwitz, et al.
American Journal of Clinical Dermatology|May 10, 2022
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial DataChristiane Querfeld, Julia J Scarisbrick, Chalid Assaf, et al.
Leukemia & Lymphoma|October 29, 2009
Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer CenterChristiane Querfeld, Neha Mehta, Steven T Rosen, et al.
Dermatology and Therapy|November 27, 2024
Chlormethine Gel for Treatment of Patients with Mycosis Fungoides: Best Practices and Guidance to CliniciansLarisa Geskin, Christiane Querfeld, Emmilia Hodak, et al.
Journal of the American Academy of Dermatology|March 21, 2007
Phase II trial of subcutaneous injections of human recombinant interleukin-2 for the treatment of mycosis fungoides and Sézary syndromeChristiane Querfeld, Steven T Rosen, Joan Guitart, et al.
Frontiers in Medicine|February 2, 2024
Expert opinions and clinical experiences with chlormethine gel as maintenance treatment for patients with mycosis fungoidesLarisa Geskin, Christiane Querfeld, Emmilia Hodak, et al.
Best Practice & Research. Clinical Haematology|October 6, 2019
Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndromeXochiquetzal U Martinez, Cosimo Di Raimondo, Farah R Abdulla, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 6, 2023
Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment ExperiencesLarisa J Geskin, James T Angello, Martine Bagot, et al.
Pageof 14